Advertisement
Advertisement
XLO
Xilio Therapeutics, Inc. Common Stock
9.01
USDSponsored
+0.11
+1.24%
Jun 24, 16:00 UTC -4
Closed
After-Market
9.01
0.00
0.00%
XLO Earnings Reports
Positive Surprise Ratio
XLO beat 13 of 20 last estimates.
65%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Xilio Therapeutics, Inc. Common Stock earnings per share and revenue
On May 12, 2026, XLO reported earnings of -0.57 USD per share (EPS) for Q1 26, beating the estimate of -0.66 USD, resulting in a 12.99% surprise. Revenue reached 12.65 million, compared to an expected 8.61 million, with a 46.98% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Xilio Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Xilio Therapeutics, Inc. Common Stock reported EPS of -$0.57, beating estimates by 12.99%, and revenue of $12.65M, 46.98% above expectations.
How did the market react to Xilio Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- 0%, changed from $7.73 before the earnings release to $7.73 the day after.
When is Xilio Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Xilio Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Xilio Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement